Placental Distribution and the Effect of Antihypertensive Drugs on Monoamine Oxidase and Cathechol-o-Methyl Transferase Activity at Term

  • Eytan R. Barnea
  • A. H. De Cherney
  • Frederick Naftolin
Part of the Trophoblast Research book series (TR)


Pregnancy associated with hypertension frequently requires antihypertensive medications, which among other effects should improve the uteroplacental circulation. The mechanism and site of action of the commonly used antihypertensive drugs (AHD) used in pregnancy in the circulation has been previously investigated (Lunell et al., 1981; Johanson et al., 1980, Freed et al., 1978; Moskowitz and Cohn, 1980). Unfortunately, knowledge concerning mechanism of action of this group of AHD on the placenta and the uterus is limited. It has been suggested that their effect among others may be mediated via a direct action on the placental blood vessel wall. Moreover, beta adrenergic receptors were found in the brush border membrane of the placenta where some AHD could exert their action (Moore and Whitsett, 1981; Karlsson et al., 1984; Maigaard et al., 1984). Other effects might be exerted on metabolizing enzymes for placental catecholamine and serotonin, monoamine oxidase (MAO) and catechol-o-methyl transferase (COMT). The activities of these metabolizing enzymes have been shown previously to be lower in placentae of patients with hypertension (Barnea et al., 1983, 1986) where a high concentration of norepinephrine was found (DeMaria, 1966). In addition, alpha methyl DOPA and hydralazine can interact with COMT and MAO, respectively in other tissues (Gordonsmith et al., 1982; Lyles et al., 1983).


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Barnea, E.R., MacLusky, N.J., and Naftolin, F. (1983) Catecholamine metabolism in the human term placenta. Soc. Gyn. Invest. (Abstract), 283.Google Scholar
  2. Barnes, E.R., MacLusky, N.J., and Naftolin, F. (1986) Monoamine oxidase activity in the human placenta at term. Am. J. Perinat. 3, 219 - 224.CrossRefGoogle Scholar
  3. Bates, G.W., Edman, C.D., Porter, J.C., Johnston, J.M., and MacDonald, P.C. (1979) An assay for human erythrocyte catechol-o-methyl transferase activity using a catechol estrogen as the substrate. Clin. Chem. Acta 94, 63 - 69.CrossRefGoogle Scholar
  4. Casey, M.L. and MacDonald, P.C. (1983) Characterization of catechol-o-methyltransferase activity in human uterine decidua vera tissue. Am. J. Obstet. Gynecol. 145, 453 - 457.PubMedGoogle Scholar
  5. DeMaria, F.J. and See, H.Y.C. (1966) Role of the placenta in pre-eclampsia. Am. J. Obstet. Gynecol. 77, 412 - 416.Google Scholar
  6. Freed, C.R., Murphy, R.C., and Quintero, E. (1978) Blood pressure reduction and hypothalamic a-methyl-DOPA metabolism after long term a-methyl-DOPA infusions. Clin. Res. 26, 100A.Google Scholar
  7. Gordonsmith, R.H., Raxworthy, M.J., and Gulliver, P.A. (1982) Substrate stereo-specificity and selectivity of catechol-o-methyl transferase for DOPA, DOPA derivatives, and a-substituted catecholamines. J. Pharmacol. 31, 433 - 439.Google Scholar
  8. Jeffery, D.R. and Roth, J.A. (1984) Characterization of membrane-bound and soluble catechol-o-methyl transferase from human frontal cortex. J. Neurochem. 42, 826 - 832.PubMedCrossRefGoogle Scholar
  9. Jouppila, P., Kirkinen, P., Koivula, A., and Ylikorkala, O. (1985) Effects of dehydralazine infusion on the fetoplacental blood flow and maternal prostanoids. Obstet. Gynecol. 65, 115 - 118.PubMedGoogle Scholar
  10. Karlsson, K., Lundren, Y., and Ljungblad, U. (1984) The acute effect of a non-selective ß-adrenergic blocking agent in hypertensive pregnant rats. Acta Obstet. Gynecol. Scand. (Suppl.) 118, 81 - 85.Google Scholar
  11. Lowry, O.H., Rosebrough, N., Farr, A.L., and Randall, R.J. (1951) Protein measurement with the pholin phenol reagent. Biol. Chem. 193, 265 - 269.Google Scholar
  12. Lueck, J. and Aladjem, S. (1982) Effect of therapeutic levels of magnesium sulphate, methyl dopa, hydralazine and phenobarbitone on normal human trophoblast in vitro. Placenta 3, 39 - 44.PubMedCrossRefGoogle Scholar
  13. Lunell, N.O., Hjendahl, P., and Fredholm, B.B. (1981) Circulatory and metabolic effects of a combined and -ß-adrenoreceptor blocker (labetalol) in hypertension of pregnancy. Br. J. Pharmacol. 15, 345 - 349.CrossRefGoogle Scholar
  14. Lyles, A.G., Garcia-Rodriguez, J., and Callingham, B.A. (1983) Inhibitory actions of hydralazine upon monoamine oxidizing enzymes in the rat. Biochem. 32, 25152520.Google Scholar
  15. Maigaard, S., Forman, A., and Andersson, K.E. (1984) Effects of nifedipine on human placental arteries. Gynecol. Obstet. Invest. 18, 217 - 221.PubMedCrossRefGoogle Scholar
  16. Moore, J. and Whitsett, J. (1981) The beta-adrenergic receptor in human placenta: Receptor subtype analysis and partial characterization of the solubilized receptor. Placenta Suppl. 3, 103 - 114PubMedGoogle Scholar
  17. Moskowitz, R. and Cohn, T. (1980) Hemodynamic effects of oxdralazine and hydralazine in hypertension. Clin. Pharmacol. Ther. 27, 773 - 777.PubMedCrossRefGoogle Scholar
  18. Nandakumaran, M., Gardey, C., Challier, J.C., and Oliver, G. (1983) Placental monoamine oxidase content and inhibition: effect of enzyme inhibition on maternofetal transfer of noradrenaline in the human placenta in vitro. Placenta 4, 57 - 62.PubMedCrossRefGoogle Scholar
  19. Parvez, H. and Parvez, S. (1973) Micro radioisotopic determination of enzymes catechol-o-methyltransferase, phenyletyhanolamine-n-methyl-transferase and monoamine oxidase in a single concentration of tissue homogenate. Clin. Chem. Acta 40, 85 - 92.CrossRefGoogle Scholar
  20. O’Shaugnessy, R.W. and Zuspan, F.P. (1982) Uterine catecholamines in normal and hypertensive human pregnancy. Clin. Exp. Hypertens. 2 (Abstract), 183.Google Scholar
  21. Sibai, B.M., Graham, J.M. and McCubbin, J.H. (1984) A comparison of intravenous and intramuscular magnesium sulphate regimens in preeclampsia. Am. J. Obstet. Gynecol. 149, 128 - 150.Google Scholar
  22. Weinshilbum, R.M. and Raymond, F.A. (1976) Calcium inhibition of rat catechol-omethyl transferase. Biochem. Pharmacol. 25, 573 - 577.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • Eytan R. Barnea
    • 1
  • A. H. De Cherney
    • 1
  • Frederick Naftolin
    • 1
  1. 1.Department of Obstetrics and GynecologyYale University School of MedicineNew HavenUSA

Personalised recommendations